Viewing Study NCT00891267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-03-03 @ 10:20 AM
Study NCT ID: NCT00891267
Status: COMPLETED
Last Update Posted: 2018-12-24
First Post: 2009-04-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metabolic Syndrome View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inflammatory markers View
None Vascular protection View
None OM Effect View
None Metabolic syndrome View
None Hypertension View